Prognostic Value of Excision Repair Cross-Complementing Gene 1, Dihydropyrimidine Dehydrogenase, and Human Equilibrative Nucleotide Transporter 1 Expression and Their Implications for Adjuvant Treatment in Patients With Ampullary Carcinoma. [electronic resource]
Producer: 20160411Description: 937-44 p. digitalISSN:- 1536-4828
- Adult
- Aged
- Aged, 80 and over
- Ampulla of Vater -- enzymology
- Biomarkers, Tumor -- analysis
- Carcinoma -- enzymology
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Common Bile Duct Neoplasms -- enzymology
- DNA-Binding Proteins -- analysis
- Dihydrouracil Dehydrogenase (NADP) -- analysis
- Disease Progression
- Disease-Free Survival
- Endonucleases -- analysis
- Equilibrative Nucleoside Transporter 1 -- analysis
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local
- Pancreaticoduodenectomy -- adverse effects
- Patient Selection
- Proportional Hazards Models
- Retrospective Studies
- Risk Factors
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.